Black Diamond Therapeutics (BDTX) Change in Acquisitions & Divestments (2020 - 2021)
Historic Change in Acquisitions & Divestments for Black Diamond Therapeutics (BDTX) over the last 2 years, with Q4 2021 value amounting to $48.5 million.
- Black Diamond Therapeutics' Change in Acquisitions & Divestments fell 3370.97% to $48.5 million in Q4 2021 from the same period last year, while for Dec 2021 it was $182.8 million, marking a year-over-year increase of 10107.23%. This contributed to the annual value of $139.8 million for FY2024, which is 7877.47% up from last year.
- As of Q4 2021, Black Diamond Therapeutics' Change in Acquisitions & Divestments stood at $48.5 million, which was down 3370.97% from $39.2 million recorded in Q3 2021.
- Black Diamond Therapeutics' Change in Acquisitions & Divestments' 5-year high stood at $73.2 million during Q4 2020, with a 5-year trough of $17.8 million in Q3 2020.